±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 552  |  »Ø¸´: 7
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

renlintyut

Òø³æ (СÓÐÃûÆø)

[½»Á÷] ×Ïɼ´¼µÄÎïÐÔ£¨¼±£©

Çë½ÌÈçÌâ×Ïɼ´¼µÄÎïÐÔÊý¾Ý£¬ÈçËüµÄÈÛµã·ÐµãÁÙ½çÐÔÖÊ£¬ÁÙ½çѹÁ¦ÁÙ½çζȵȣ¬ÒòΪʵÑé³öÁËЩÎÊÌ⣬¼±°¡£¬ÇëÇó½â´ð£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yulaizai2000

½ð³æ (СÓÐÃûÆø)

¡ï
xy4585618(½ð±Ò+1,VIP+0):3q
Monograph Number:  7052
Title:  Paclitaxel
CAS Registry Number:  33069-62-4
CAS Name:  [2aR-[2aa,4b,4ab,6b,9a(aR*,bS*),11a,12a,12aa,12ba]]-b-(Benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester
Additional Names:  5b,20-epoxy-1,2a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine;  taxol A
Manufacturers' Codes:  NSC-125973
Trademarks:  Anzatax (Faulding);  Paxene (Baker Norton);  Taxol (Bristol-Myers Squibb)
Molecular Formula:  C47H51NO14
Molecular Weight:  853.90.  
Percent Composition:  C 66.11%, H 6.02%, N 1.64%, O 26.23%
Literature References:  Antileukemic and antitumor agent first isolated, as the l-form, from the bark of the Pacific yew tree, Taxus brevifolia, Taxaceae; promotes the assembly of microtubules and inhibits the tubulin disassembly process.  Isoln and structure:  M. C. Wani et al., J. Am. Chem. Soc. 93, 2325 (1971).  In vitro promotion of microtubule assembly:  P. B. Schiff et al., Nature 277, 665 (1979).  Isoln from Taxus baccala L. and in vitro inhibition of depolymerization of microtubules into tubulin:  G. Chauviere et al., C.R. Acad. Sci. Paris Ser. II 293, 501 (1981).  Total synthesis of taxusin, which contains the entire ring skeleton:  R. A. Holton et al., J. Am. Chem. Soc. 110, 6558 (1988).  Total stereosynthesis:  R. A. Holton et al., ibid. 116, 1597, 1599 (1994); K. C. Nicolaou et al., Nature 367, 630 (1994).  Synthesis and anticancer activity of derivs:  D. G. I. Kingston et al., Studies in Organic Chemistry vol. 26, entitled "New Trends in Natural Products Chemistry 1986", Atta-ur-Rahman, P. W. Le Quesne, Eds. (Elsevier, Amsterdam, 1986) pp 219-235.  Production by Taxomyces andreanae, an endophytic fungus associated with T. brevifolia:  A. Stierle et al., Science 260, 214 (1993).  Use in study of structure and function of microtubules:  S. B. Horwitz et al., Cold Spring Harbor Symp. Quant. Biol. 46, 219 (1982).  Clinical evaluation in Kaposi's sarcoma:  M. W. Saville et al., Lancet 346, 26 (1995).  Review of mechanism of action:  J. J. Manfredi, S. B. Horwitz, Pharmacol. Ther. 25, 83-125 (1984); S. B. Horwitz et al., Ann. N.Y. Acad. Sci. 466, 733-744 (1986); S. B. Horwitz, Trends Pharmacol. Sci. 13, 134-136 (1992).  Symposium on clinical toxicology, pharmacology and efficacy:  Sem. Oncol. 20, Suppl. 3, 1-60 (1993).  Review in ovarian cancer:  C. D. Runowicz et al., Cancer 71, 1591-1596 (1993).  Book:  Taxol?  Science and Applications, M. Suffness, Ed. (CRC Press, Boca Raton, 1995) 426 pp.
Properties:  Needles from aq methanol, mp 213-216?(dec).  [a]D20 -49?(methanol).  uv max (methanol):  227, 273 nm (e 29800, 1700).
Melting point:  mp 213-216?(dec)
Optical Rotation:  [a]D20 -49?(methanol)
Absorption maximum:  uv max (methanol):  227, 273 nm (e 29800, 1700)
Use:  Tool in study of structure and function of microtubules.
Therap-Cat:  Antineoplastic.
4Â¥2008-08-22 10:07:02
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 8 ¸ö»Ø´ð

¶¹¸ç

Ö÷¹ÜÇø³¤ (Ö°Òµ×÷¼Ò)

ÖÆÁ£ÄÜÊÖ

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡ï
xy4585618(½ð±Ò+1,VIP+0):3q
È۵㠠213-216 ºC
±ßѧ±ßÎÊ£¬²ÅÓÐѧÎÊ¡£
2Â¥2008-08-21 23:32:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

renlintyut

Òø³æ (СÓÐÃûÆø)

Ŷ£¬Ð»Ð»ÁË£®ÄÇËüµÄÁÙ½çÖµÁË£¿
3Â¥2008-08-22 09:15:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

renlintyut

Òø³æ (СÓÐÃûÆø)

лл£¬ÄÇÎÒ²é²é¿´£®
»¶Ó­¶à¸øÎÒÒâ¼û½¨Òéà¸
5Â¥2008-08-22 16:58:38
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 266·Ö£¬Çó²ÄÁÏÏà¹Ø×¨Òµµ÷¼Á +13 ÍÛºôºßºôºß 2026-03-30 15/750 2026-04-03 15:24 by arrow8852
[¿¼ÑÐ] Çóµ÷¼Á»ú»á +5 ÒâȾivy 2026-04-03 5/250 2026-04-03 15:13 by qoooooo614
[¿¼ÑÐ] µ÷¼Á +4 asdasdassda 2026-04-03 5/250 2026-04-03 14:02 by °ÙÁéͯ888
[¿¼ÑÐ] 298·Ö 070300Çóµ÷¼Á +11 zwen03 2026-04-02 11/550 2026-04-03 10:19 by macy2011
[¿¼ÑÐ] 262Çóµ÷¼Á +6 ÀøÖ¾Ò»¶¨·¢ÎÄÕ 2026-04-02 7/350 2026-04-03 09:54 by linyelide
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 bvzz 2026-04-01 3/150 2026-04-03 09:47 by À¶ÔÆË¼Óê
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 085602 ÕÒµ÷¼Á +3 ÄæÊ±Õë¿ìÀÖ 2026-04-02 3/150 2026-04-02 21:23 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö +3 ÄÏɽÄÏ@ 2026-04-01 3/150 2026-04-02 12:09 by xiaoranmu
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358 +8 cs0106 2026-04-01 9/450 2026-04-02 10:36 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á +10 ÄØÄØÄÝÄÝ 2026-04-01 13/650 2026-04-02 09:17 by olim
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +10 Eujd1 2026-03-31 11/550 2026-04-01 11:23 by ivanqyq
[¿¼ÑÐ] 080200ѧ˶£¬»úе¹¤³Ìרҵ277·Ö£¬Çó´ø×ߣ¡ +4 Æ¿×ÓPZ 2026-03-31 4/200 2026-03-31 20:16 by vgtyfty
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +13 ÉîVËÞÉá°É 2026-03-29 13/650 2026-03-31 19:50 by Dyhoer
[¿¼ÑÐ] 254²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +3 º²¶¬ÁÖéª 2026-03-30 4/200 2026-03-31 17:53 by yishunmin
[¿¼ÑÐ] 080500-315·Ö¸´ÊÔµ÷¼Á +9 Éϰ¶3821 2026-03-31 9/450 2026-03-31 17:29 by ÌÆãå¶ù
[¿¼ÑÐ] 353Çóµ÷¼Á +3 ½­ÉÏ·ã_26 2026-03-28 3/150 2026-03-31 15:53 by jp9609
[¿¼ÑÐ] 083000»·¾³¿ÆÑ§Ó빤³Ìµ÷¼Á£¬×Ü·Ö281 +4 ³È×Ó£¨Ê¤Ò⣩ 2026-03-30 4/200 2026-03-31 00:44 by Linzejun
[¿¼ÑÐ] 296Çóµ÷¼Á +10 ±Ë°¶t 2026-03-29 10/500 2026-03-30 10:50 by ̽123
[¿¼ÑÐ] 291Çóµ÷¼Á +5 Y-cap 2026-03-29 6/300 2026-03-29 13:18 by mumin1990
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û